InCarda at Biotech Industry Organization’s (BIO) International Conference 2019
June 3-6, 2019 – Philadelphia, PA
“Addressing Unmet Need in Cardiovascular Disease” Panel
At the 2019 Biotech Industry Organization’s (BIO) International Conference held in June in Philadelphia, InCarda’s CEO, Dr. Grace Colon, was a participant on a panel of distinguished experts entitled “Addressing Unmet Need in Cardiovascular Disease.” The session focused on highlighting areas of high unmet need, such as atrial fibrillation, as well as on strategies to accelerate drug development, including incorporating digital health tools for improved enrollment and tracking.
“Non-traditional CEOs” Panel
At the conference, Dr. Colon was also moderator for a panel entitled “Non-traditional CEOs and Founders – How to Win in a Traditional World.” Additionally, InCarda’s Head of Corporate Development and Co-Founder/COO of Cadence Health, Samantha Miller, participated in this panel which discussed the challenges for underrepresented minorities and women in the corporate world and, particularly, start-ups.
About the BIO International Convention
The BIO International Convention annually brings together global biotech and pharma leaders to offer partnering opportunities, exposure to industry thought-leaders, education sessions, and networking opportunities with 16,000+ attendees from 67 countries.
For more information – https://convention.bio.org/2019/